...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Why now?

Hi Koo - all my shares were spinoff shares from Newco (from RVX) and has the same CUSIP # as ZHCLF so I don't have a reason to believe they would be any different.  

I'm tempted to make a purchase on the OTC to see if they will merge my shares.

Share
New Message
Please login to post a reply